NVRO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Stats
Today's Volume	276 262
Average Volume	458 369
Market Cap	412.02M
EPS	$0 ( 2024-04-24 )
Next earnings date	( $-1.020 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.42
ATR14	$0.0110 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Thornal Kevin R	Sell	24 233	Common Stock
2024-04-11	Grossman D Keith	Sell	3 986	Common Stock
2024-04-04	Rashid Kashif	Sell	479	Common Stock
2024-03-31	Kosaraju Sridhar	Buy	1 090	Common Stock
2024-03-31	Demane Michael F	Buy	1 817	Common Stock

INSIDER POWER
60.35
Last 97 transactions
Buy: 980 834 \| Sell: 269 822

Volume Correlation

Long: 0.06 (neutral)

Short: 0.90 (strong)

Signal:(46.709) Same movement expected

Nevro Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nevro Corp Correlation - Currency/Commodity

-0.25
( neutral )

-0.42
( neutral )

0.00
( neutral )

0.28
( neutral )

-0.47
( neutral )

Nevro Corp Financials

Annual	2023
Revenue:	$425.17M
Gross Profit:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2023
Revenue:	$425.17M
Gross Profit:	$278.53M (65.51 %)
EPS:	$-2.56

FY	2022
Revenue:	$406.37M
Gross Profit:	$276.37M (68.01 %)
EPS:	$0.0850

FY	2021
Revenue:	$386.91M
Gross Profit:	$266.04M (68.76 %)
EPS:	$-3.77

Financial Reports:

No articles found.

Nevro Corp

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.